Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Washington resident contracts bird flu, first human case in U.S. since February - 2From Sea shores to Urban areas: Astonishing Worldwide Travel Objections
- 3Yasser Abu Shabab's killing raises questions about Israel's militia strategy in Gaza
- 4Is new Harry Styles music on the way? Fans think so, after a cryptic website and posters pop up.
- 5How to watch 2026 Golden Globe winners like 'One Battle After Another,' 'Adolescence' and 'The Pitt'
- Popular Film Areas: A Worldwide Manual for Film Enchantment
- What causes RFK Jr.’s strained and shaky voice? A neurologist explains this little-known disorder
- Inside the cockpit of RAF tanker during defensive mission against Iranian drones
- Novo Nordisk slashes prices of popular weight loss and diabetes drugs
- Interstellar comet 3I/ATLAS reveals weird wobbling jets in rare sun-facing tail
- Wedding trip Objections in Europe
- Geminid shooting stars: One of 2025's most exciting meteor showers begins tonight
- Internet Bookkeeping Programming for Consultants
- Manual for Tracking down the Immaculate Magnificence of Focal Asia
